About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 62 women aged 18 to 34 at high OHSS risk, Hammersmith Hospital IVF unit, London
- Sample size
- 62
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 13 August 2026
Limitations
Single dose-interval tested; oocyte retrieval timing may not capture the full benefit window per authors; underpowered for implantation-rate comparisons.
Cited in
Repeat injection, 62 women
Kisspeptin · Research finding
LimitedOHSS incidence, repeat injection
Kisspeptin · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.